Immune Therapeutics Adds Experienced New Board Member Saiid Zarrabian

ORLANDO, FL, IMUN, / ACCESSWIRE / Immune Therapeutics, Inc., a U.S. public company (OTCQB: IMUN), announces the appointment of Saiid Zarrabian as Immune s newest board member. Immune is pleased to add Mr. Zarrabian s 37 years of experience in biotechnology, pharmaceutical, informatics, software and instrumentation/hardware industries to its team. Most recently, Mr. Zarrabian was founding Chairman at La Jolla Pharmaceutical after it was reorganized with new funding, new management team & new products in early 2012. From 2012 to 2013, he was President of the Protein Production Division and Senior Vice President of Intrexon, Inc., a synthetic biology company. From 2010 through 2012, he was President and Chief Executive Officer of Cyntellect, Inc., an instrumentation company with stem cell processing and cell visualization products. Mr. Zarrabian also served as President and Chief Operating Officer of Senomyx, Inc., a public biotechnology company focused on the discovery and commercializa


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: